РАДаР - Репозиторијум Архивираних Дигиталних Радова
Институт за биолошка истраживања "Синиша Станковић"
    • English
    • Српски
    • Српски (Serbia)
  • Српски (ћирилица) 
    • Енглески
    • Српски (ћирилица)
    • Српски (латиница)
  • Пријава
Преглед рада 
  •   ИБИСС РАДаР
  • IBISS
  • Article
  • Преглед рада
  •   ИБИСС РАДаР
  • IBISS
  • Article
  • Преглед рада
JavaScript is disabled for your browser. Some features of this site may not work without it.

Novel inhibitors of macrophage migration inhibitory factor prevent cytokine-induced beta cell death

2014
Аутори:
Vujičić, Milica
Nikolić, Ivana
Krajnović, Tamara
Cheng, Kai-Fan
VanPatten, Sonya
He, Mingzhu
Stošić-Grujičić, Stanislava D.
Stojanovic, Ivana
Al-Abed, Yousef
Saksida, Tamara
Тип документа:
Чланак у часопису
Метаподаци
Приказ свих података о документу
Апстракт:
Macrophage migration inhibitory factor is a multifunctional cytokine involved in the regulation of immune processes and also in apoptosis induction. Elevated MIF expression is detrimental for insulin-producing beta cells and MIF inhibition protected beta cells from several cytotoxic insults such as inflammatory cytokines, high fatty acids or high glucose concentrations. Therefore, the aim of this study was to investigate two newly synthesized small molecule MIF inhibitors (K664-1 and K647-1) and to compare them with previously established effects of the prototypical MIF inhibitor, ISO-1. Our results indicate that K664-1 and K647-1 are 160- and 40-fold more effective in inhibition of MIF's tautomerase activity than ISO-1. Also, new inhibitors confer beta cell protection from cytokine-triggered apoptosis at significantly lower concentrations than LSO-1. Although all three MIF inhibitors inhibit caspase 3 activity, K664-1 and K647-1 suppress pro-apoptotic BAX protein expression and up-regulate anti-apoptotic Bcl-2 mRNA. Finally, all three MIF inhibitors operate through blockade of nitric oxide production stimulated by cytokines. In conclusion, two novel MIF inhibitors are more potent than ISO-1 and operate through inhibition of the mitochondria-related apoptotic pathway. We propose that these compounds represent a unique class of anti-MIF antagonists that should be further tested for therapeutic use. (C) 2014 Elsevier B.V. All rights reserved.
Кључне речи:
Macrophage migiration inhibitory factor; Diabetes; Cytokines; Apoptosis
Извор:
European Journal of Pharmacology, 2014, 740, 683-689

DOI: 10.1016/j.ejphar.2014.06.009

ISSN: 1879-0712

WoS: 000341163700084

[ Google Scholar ]
URI
http://ibiss-r.rcub.bg.ac.rs/123456789/2141
Колекције
  • Article
Институција
IBISS

DSpace software copyright © 2002-2015  DuraSpace
О ИБИСС РАДаР репозиторијуму | Пошаљите запажања

RCUB
 

 

Комплетан репозиторијумКолекцијеАуториПо датуму издавањаТемеОва институцијаАуториПо датуму издавањаТеме

DSpace software copyright © 2002-2015  DuraSpace
О ИБИСС РАДаР репозиторијуму | Пошаљите запажања

RCUB